Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
28.9M
-
Shares change
-
+12.6M
-
Total reported value, excl. options
-
$201M
-
Value change
-
+$88.2M
-
Put/Call ratio
-
0.41
-
Number of buys
-
62
-
Number of sells
-
-30
-
Price
-
$6.94
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q3 2024
127 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q3 2024.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.9M shares
of 53.4M outstanding shares and own 54.13% of the company stock.
Largest 10 shareholders include Woodline Partners LP (4.05M shares), BlackRock, Inc. (3.12M shares), Nantahala Capital Management, LLC (2.92M shares), VANGUARD GROUP INC (2.76M shares), FMR LLC (2.31M shares), Altium Capital Management LP (1.7M shares), 683 Capital Management, LLC (1.23M shares), GEODE CAPITAL MANAGEMENT, LLC (1.04M shares), J. Goldman & Co LP (984K shares), and STATE STREET CORP (773K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.